Randomized Controlled Trial of Computerized MET for Adolescent Substance Use
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Drug Abuse
- Sponsor
- Boston Children's Hospital
- Locations
- 1
- Primary Endpoint
- Treatment engagement
- Status
- Withdrawn
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to test the effects of a computerized, self-directed Motivational Enhancement Therapy program for adolescent substance use (iMET), in comparison to clinician-delivered MET and Treatment As Usual (TAU), on treatment engagement and substance use. The investigators hypothesize that both iMET and MET will be more effective than TAU in engaging/retaining patients in treatment and in reducing substance use during a 12-month follow-up period. The investigators also hypothesize that Self-directed iMET will be as effective as the clinician-guided MET in increasing treatment engagement and abstinence during the 12-months follow-up period.
Investigators
Sion Kim Harris
Co-Director, Center for Adolescent Substance Abuse Research
Boston Children's Hospital
Eligibility Criteria
Inclusion Criteria
- •completed initial visit at the treatment program;
- •be available to return for iMET/MET sessions (if assigned)
- •be available to complete all follow-up measurements
- •a past-12-month CRAFFT score \>1
- •have used substances on \>6 days (not including tobacco use) during the 90 days preceding their visit
Exclusion Criteria
- •unable to speak and understand English, or read English at a 5th grade reading level
- •youth deemed by the clinical team to require immediate hospitalization or referral to more intensive residential treatment
Outcomes
Primary Outcomes
Treatment engagement
Time Frame: 12 months
We will compare the number of individual visits in the program, the number of group sessions completed, and the number of urine screens completed during a 12 month follow-up period by each participant in the three study arms.
Secondary Outcomes
- Days abstinent(past-90-days)
- Driving/Riding Risk(past-90-days)
- HIV Risk Behavior(past-90-days)